Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $155,626 - $363,918
-2,154 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $575,064 - $818,629
-4,580 Reduced 68.01%
2,154 $367,000
Q3 2020

Nov 16, 2020

SELL
$127.12 - $172.34 $777,465 - $1.05 Million
-6,116 Reduced 47.6%
6,734 $946,000
Q2 2020

Aug 14, 2020

BUY
$93.0 - $171.7 $941,811 - $1.74 Million
10,127 Added 371.91%
12,850 $2.06 Million
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $280,092 - $447,575
-3,400 Reduced 55.53%
2,723 $266,000
Q4 2019

Feb 12, 2020

BUY
$76.53 - $135.58 $468,593 - $830,156
6,123 New
6,123 $790,000
Q3 2019

Nov 14, 2019

SELL
$72.81 - $156.91 $3.81 Million - $8.22 Million
-52,360 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $473,526 - $641,229
4,220 Added 8.77%
52,360 $7.96 Million
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $1.38 Million - $1.96 Million
12,892 Added 36.58%
48,140 $5.74 Million
Q4 2018

Feb 14, 2019

SELL
$97.32 - $148.76 $868,289 - $1.33 Million
-8,922 Reduced 20.2%
35,248 $3.85 Million
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $2.49 Million - $3.48 Million
-21,576 Reduced 32.82%
44,170 $7.13 Million
Q2 2018

Aug 14, 2018

BUY
$71.74 - $153.69 $804,707 - $1.72 Million
11,217 Added 20.57%
65,746 $8.69 Million
Q1 2018

May 15, 2018

SELL
$54.02 - $82.27 $1.4 Million - $2.13 Million
-25,937 Reduced 32.23%
54,529 $4.04 Million
Q4 2017

Feb 14, 2018

BUY
$47.64 - $56.75 $357,776 - $426,192
7,510 Added 10.29%
80,466 $4.48 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $2.61 Million - $3.44 Million
72,956
72,956 $3.31 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.